Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hae-Ki Min

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Plos One|July 30, 2014
Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfateShunlin Ren, Jin Koung Kim, Genta Kakiyama, et al.
Plos One|September 1, 2015
Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver DiseaseTommy Pacana, Sophie Cazanave, Aurora Verdianelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cellsLawrence B Schwartz, Hae-Ki Min, Shunlin Ren, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 14, 2023
Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivoYaping Wang, Williams M Pandak, Phillip B Hylemon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 25, 2016
Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responsesHae-Ki Min, Hitoshi Maruyama, Byoung Kuk Jang, et al.
Molecular Pharmacology|December 22, 2012
5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse modelLeyuan Xu, Jin Koung Kim, Qianming Bai, et al.
Cell Metabolism|May 8, 2012
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver diseaseHae-Ki Min, Ashwani Kapoor, Michael Fuchs, et al.
Journal of Visualized Experiments : Jove|August 9, 2016
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density LipoproteinMulugeta Seneshaw, Faridoddin Mirshahi, Hae-Ki Min, et al.
Journal of Lipid Research|March 30, 2016
Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obesePuneet Puri, Jun Xu, Terhi Vihervaara, et al.
Biological & Pharmaceutical Bulletin|September 17, 2002
Expression of cyclooxygenase-2 and pro-inflammatory cytokines induced by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) in human mast cells requires NF-kappa B activationOkyun Kwon, Eunkyung Lee, Tae Chul Moon, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Plos One|July 30, 2014
Identification of novel regulatory cholesterol metabolite, 5-cholesten, 3β,25-diol, disulfateShunlin Ren, Jin Koung Kim, Genta Kakiyama, et al.
Plos One|September 1, 2015
Dysregulated Hepatic Methionine Metabolism Drives Homocysteine Elevation in Diet-Induced Nonalcoholic Fatty Liver DiseaseTommy Pacana, Sophie Cazanave, Aurora Verdianelli, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 22, 2003
Tryptase precursors are preferentially and spontaneously released, whereas mature tryptase is retained by HMC-1 cells, Mono-Mac-6 cells, and human skin-derived mast cellsLawrence B Schwartz, Hae-Ki Min, Shunlin Ren, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|November 14, 2023
Cholestenoic acid as endogenous epigenetic regulator decreases hepatocyte lipid accumulation in vitro and in vivoYaping Wang, Williams M Pandak, Phillip B Hylemon, et al.
FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|August 25, 2016
Suppression of IGF binding protein-3 by palmitate promotes hepatic inflammatory responsesHae-Ki Min, Hitoshi Maruyama, Byoung Kuk Jang, et al.
Molecular Pharmacology|December 22, 2012
5-cholesten-3β,25-diol 3-sulfate decreases lipid accumulation in diet-induced nonalcoholic fatty liver disease mouse modelLeyuan Xu, Jin Koung Kim, Qianming Bai, et al.
Cell Metabolism|May 8, 2012
Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver diseaseHae-Ki Min, Ashwani Kapoor, Michael Fuchs, et al.
Journal of Visualized Experiments : Jove|August 9, 2016
Fast and Simplified Method for High Through-put Isolation of miRNA from Highly Purified High Density LipoproteinMulugeta Seneshaw, Faridoddin Mirshahi, Hae-Ki Min, et al.
Journal of Lipid Research|March 30, 2016
Alcohol produces distinct hepatic lipidome and eicosanoid signature in lean and obesePuneet Puri, Jun Xu, Terhi Vihervaara, et al.
Biological & Pharmaceutical Bulletin|September 17, 2002
Expression of cyclooxygenase-2 and pro-inflammatory cytokines induced by 2,2',4,4',5,5'-hexachlorobiphenyl (PCB 153) in human mast cells requires NF-kappa B activationOkyun Kwon, Eunkyung Lee, Tae Chul Moon, et al.
Pageof 4